Research progress on specific and non-specific immune effects of BCG and the possibility of BCG protection against COVID-19
Bacille Calmette-Guérin (BCG) is the only approved vaccine for tuberculosis (TB) prevention worldwide. BCG has an excellent protective effect on miliary tuberculosis and tuberculous meningitis in children or infants. Interestingly, a growing number of studies have shown that BCG vaccination can indu...
Huvudupphovsmän: | Jingli Du, Yue Su, Ruilan Wang, Enjun Dong, Yan Cao, Wenjuan Zhao, Wenping Gong |
---|---|
Materialtyp: | Artikel |
Språk: | English |
Publicerad: |
Frontiers Media S.A.
2023-01-01
|
Serie: | Frontiers in Immunology |
Ämnen: | |
Länkar: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1118378/full |
Liknande verk
Liknande verk
-
A retrospective audit of neonatal BCG vaccination in Grampian, Scotland
av: Saba Savul, et al.
Publicerad: (2023-12-01) -
HUBUNGAN RIWAYAT STATUS IMUNISASI BACILLE CALMETTE-GUÉRIN (BCG) DENGAN KEJADIAN TUBERKULOSIS (TB) PADA ANAK DI BADAN LAYANAN UMUM DAERAH RUMAH SAKIT UMUM CUT MEUTIA ACEH UTARA TAHUN 2015
av: Hedya Nadhrati Surura, et al.
Publicerad: (2018-02-01) -
The safety of BCG revaccination in the context of COVID-19
av: Adriana Sánchez-García, et al.
Publicerad: (2023-12-01) -
Future of TB Prevention: An Alternative To BCG
av: Sneka P, et al.
Publicerad: (2022-10-01) -
Characterizing the BCG Induced Macrophage and Neutrophil Mechanisms for Defense Against Mycobacterium tuberculosis
av: Thomas E. Bickett, et al.
Publicerad: (2020-06-01)